Stock futures were pointing higher while the dollar fell early Friday, ending a week marked by trade developments and geopolitical events, as well as a flurry of company earnings.
These stocks were making moves in premarket trading Friday:
Trade Desk stock plummeted 29% despite posting solid second-quarter earnings. The ad-tech company announced that CFO Laura Schenkein will be replaced by Alex Kayyal—a board member who spent nearly a decade at Salesforce in executive roles—on Aug. 21. Revenue came in at $694 million, up 19% from last year and ahead of expectations. Adjusted earnings per share were in line with expectations at 41 cents. The company also forecast revenue of at least $717 million in the current quarter, also in line with estimates.
Expedia Group soared 18% after the travel booking company raised its full-year outlook on the back of second-quarter earnings that beat expectations late Thursday. Adjusted earnings per share came in at $4.24 on revenue of $3.8 billion, beating analysts’s call of $3.97 a share on revenue of $3.7 billion and driven by strong business travel demand. It now sees 2025 revenue and gross booking growth of between 3% and 5% each, up from a range between 2% and 4%, previously.
Pinterest shares fell 13% after the photo-sharing website disappointed Wall Street with its latest earnings report. Second-quarter earnings were 33 cents a share on revenue of $998 million, below the of 35 cents a share on revenue of $975 million expected by analysts, according to FactSet.
Twilio reported earnings that beat expectations late Thursday, sending shares of the cloud communications company up 13% early Friday. Revenue in the second quarter rose 13% year-over year to $1.2 billion while adjusted earnings per share came in at $1.19, comfortably ahead of estimates of $1.05 a share, according to FactSet.
Gilead Sciences stock rose 2.9% after it raised guidance on the back of strong demand for its HIV medicine and solid quarterly earnings late Thursday. CEO Daniel O’Day told Barron’s that the recent launch of its HIV prevention shot Yeztugo had started off well.
Under Armour and Wendy’s were also slated to report quarterly earnings ahead of the bell Friday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.